Zimbabwe has turned down a major American healthcare agreement valued at 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive data.
The decision was revealed following a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman later explained that the US was seeking genetic material for research and profit while was unwilling to share the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more negotiations to secure a agreement suitable to all parties so the country's critical HIV programme can be sustained.
Broader Background
This rejection follows a comparable situation in Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, 16 African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"In essence, our nation would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our population should a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were disrupting frameworks previously set up via the global organization.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing discussions with our US partners on how subsequent collaboration might be structured in a way that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that talks must proceed considering much of the country's HIV programmes were funded by external financing.
"Where specific concerns arise, including those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.
The halted deal underscores the ongoing debate between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.